<iframe src="//www.googletagmanager.com/ns.html?id=GTM-5TSRKG" height="0" width="0" style="display: none; visibility: hidden">
Research Article
No access
Published Online: 22 August 2014

Probiotic Dahi Containing Lactobacillus acidophilus and Bifidobacterium bifidum Modulates the Formation of Aberrant Crypt Foci, Mucin-Depleted Foci, and Cell Proliferation on 1,2-Dimethylhydrazine-Induced Colorectal Carcinogenesis in Wistar Rats

Publication: Rejuvenation Research
Volume 17, Issue Number 4

Abstract

Aberrant crypt foci (ACF) and mucin-depleted foci (MDF) are pre-neoplastic lesions identified in the colon of carcinogen-treated rodents and in humans at high risk for colon cancer. The present study was carried out to divulge the protective potential of the probiotic Dahi containing Lactobacillus acidophilus LaVK2 and Bifidobacterium bifidum BbVK3 alone or in combination with piroxicam (PXC) on the development of early biomarkers of colorectal carcinogenesis in male Wistar rats administered 1,2-dimethylhydrazine (DMH). DMH was injected subcutaneously at the rate of 40 mg/kg body weight per animal twice a week for 2 weeks. A total of 120 male Wistar rats were randomly allocated to five groups, each group having 24 animals. The rats were fed with buffalo milk or probiotic supplement (20 grams) alone or as an adjunct with PXC in addition to a basal diet ad libitum for 32 weeks. Group I was offered buffalo milk (BM) and served as the control group. Group II was administered DMH along with BM and served as the DMH-control group; group III was administered BM-DMH-PXC, in which besides administering BM-DMH, PXC was also offered. Group IV was offered probiotic LaBb Dahi and DMH, and group V was offered both probiotic LaBb Dahi and PXC along with DMH. The rats were euthanized at the 8th, 16th, and 32nd week of the experiment and examined for development of ACF, aberrant crypts per ACF (AC/ACF), mucin-depleted foci (MDF), large MDF, and proliferating cell nuclear antigen (PCNA) labeling index. Administration of DMH in rats induced pre-neoplastic lesions (ACF and MDF) and increased the PCNA index in colorectal tissue. A significant (p<0.05) reduction in the number of ACF, AC/ACF, MDF, large MDF, and PCNA labeling index were observed in the probiotic LaBb Dahi group compared with the DMH control group. Feeding rats with LaBb Dahi or treatment with PXC diminished the initiation and progression of DMH-induced pre-neoplastic lesions and the PCNA index, and treatment with LaBb Dahi and PXC combined was significantly more effective. The dietary intervention of probiotics and PXC significantly protects against the development of CRC in the rat-DMH model. These observations suggest that probiotic LaBb Dahi alone or as an adjunct with PXC may have anti-neoplastic and anti-proliferative activities. Moreover, probiotic LaBb Dahi possesses the medicinal properties to prevent colorectal carcinogenesis.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009;59:366–368.
2.
Mohania D, Kansal VK, Shah D. Probiotic Dahi containing Lactobacillus acidophilus and Lactobacillus plantarum suppresses DMH induced preneoplastic lesions in early colorectal carcinogenesis in Wistar Rats. Am J Cancer Biol 2013;1:1–14.
3.
Dias MC, Vieiralves NFL, Gomes MIFV, Salvadori DMF, Rodrigues MAM, Barbisan LF. Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis. Food Chem Toxicol 2010;48:772–780.
4.
Roller M, Femia AP, Caderni G, Rechkemmer G, Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 2004;92:931–938.
5.
Nishino Y, Suzuki Y, Ohmori K, Hozawa A, Ogawa K, Kuriyama S, Tsubono Y, Shibuya D, Tsuji I, Fukao A, Hisamichi S. Cancer incidence profiles in of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci 2004;95:792–797.
6.
Mohania D, Kansal VK, Sagwal R, Batish VK, Grover S, Dilip S. Anticarcinogenic effect of probiotic Dahi and piroxicam on DMH-induced colorectal carcinogenesis in Wistar rats. Am J Cancer Ther Pharmacol 2013;1:8–24.
7.
Horie H, Zeisig M, Hirayama K, Midtvedt T, Möller L, Rafter J. Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido[2,3-b]indole in a human flora-associated mouse model. Eur J Cancer Prev 2003;12:101–107.
8.
Park E, Jeon GI, Park JS, Paik HD. A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 2007;30:569–574.
9.
Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998;19:281–285.
10.
Corpet DE, Taché S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 2002;43:1–21.
11.
Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000;112;395–402.
12.
Mori M, Hata K, Yamada Y, Kuno T, Hara A. Significance and role of earlylesions in experimental colorectal carcinogenesis. Chem-Biol Interact 2005;55:1–9.
13.
Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, Lampe PD, Bronner MP, Potter JD. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidem Biomar 2005;14:605–608.
14.
Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P. Identification of mucin-depleted foci (MDF) in the unsectioned colon of azoxymethane (AOM)-treated rats: correlation with carcinogenesis. Cancer Res 2003;63:2388–2392.
15.
Femia AP, Giannini A, Fazi M, Tarquini M, Salvadori M, Roncucci L, Tonelli F, Dolara P, Caderni G. Identification of mucin depleted foci in the human colon. Cancer Prev Res 2008;1:562–567.
16.
Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P, Caderni G. Mucin-depleted foci have β-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 2005;116:9–15.
17.
Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G. Frequent mutation of Apc gene in rat colon tumors and mucin depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007;67:445–449.
18.
Femia AP, Tarquini E, Salvadori M, Ferri S, Giannini A, Dolara P, Caderni G. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine. Int J Cancer 2008;122:117–123.
19.
Femia AP, Dolara P, Caderni G. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 2004;25:277–281.
20.
Shih CK, Ho CJ, Li SC, Yang SH, Hou WC, Cheng HH. Preventive effects of rice bran oil on 1,2-dimethylhydrazine/dextran sodium sulphate-induced colon carcinogenesis in rats. Food Chem 2010;126:562–567.
21.
Chapkin RS, Lupton JR. Colonic cell proliferation and apoptosis in rodents species. Modulation by diet. Adv Exp Med Biol 1999;470:105–118.
22.
Yamada K, Yoshitke K, Sato M, Ahnen DJ. Proliferation cell nuclear antigen expression in normal, preneoplastic colonic epithelium of the rat. Gastroenterology 1992;103:160–167.
23.
Stoner GD, Morse MA, Kelloff G. Perspective in cancer chemoprevention. Nutrition and dietary carcinogenesis. Carcinogenesis 1997;21:387–395.
24.
Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000;21:387–395.
25.
Rajpal S, Kansal VK. Buffalo milk probiotic Dahi containing Lactobacillus acidophilus, Bifidobacterium bifidum and Lactococcus lactis reduces gastrointestinal culture induced by dimethylhydrazine dihydrochloride in rats. Milchwissenschaft 2008;63:122–125.
26.
Rajpal S, Kansal VK. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum attenuates diet induced hypercholesterolemia in rats. Milchwissenshaft 2009a;64:21–25.
27.
Rajpal S, Kansal VK. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum stimulates immune system in mice. Milchwissenschaft 2009b;64:147–150.
28.
Rajpal S, Kansal VK. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum stimulates antioxidant enzyme pathways in rats. Milchwissenschaft 2009c;64:287–290.
29.
Horwitz W, Latimer G. AOAC-Association of Official Analytical Chemists, Official Methods of Analysis of AOAC International, 18th ed, Gaithersburg, MD, 2005;45:75–76.
30.
Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37;147–151.
31.
Kanna PS, Mahendrakumar CB, Chatterjee M, Hemalatha P, Datta S, Chakraborty P. Vanadium inhibits placental glutathione S-transferase (GST-P) positive foci in 1,2-dimethyl hydrazine induced rat colon carcinogenesis. J Biochem Mol Toxic 2003;17:357–365.
32.
Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, Lampe PD, Bronner MP, Potter JD. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 2005;14:605–608.
33.
Tsukamoto T, Kozaki KI, Nishikawa Y, Yamamoto M, Fukami H, Inoue M. Development and distribution of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn J Cancer Res 1999;90:720–725.
34.
Kristiansen E, Thorup I, Meyer O. Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 1995:23:151–159.
35.
Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scassellati-Sforzolini R, Rowland I. Lactobacillus and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer 1996;26:365–380.
36.
Horie H, Zeisig M, Hirayama K, Midtvedt T, Möller L, Rafter J. Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido[2,3-b]indole in a human–flora associated mouse model. Eur J Cancer Prev 2003;12:101–107.
37.
Park E, Jeon GI, Park JS, Paik HD. A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 2007;30:569–574.
38.
Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002;23:1953–1960.
39.
Fauser JK, Prisciandaro LD, Cummins A, Howarth GS. Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer Biol Ther 2011;11:724–731.
40.
Fauser JK, Matthews GM, Cummins AG, Howarth GS. Induction of apoptosis by the medium-chain length fatty acid lauric acid in colon cancer cells due to induction of oxidative stress. Chemotherapy 2013;59:214–224.
41.
Matthews GM, Howarth GS, Butler RN. Short-chain fatty acid modulation of apoptosis in the kato iii human gastric carcinoma cell line. Cancer Biol Ther 2007;6:1051–1057.
42.
Young GP, Hu Y, Le Leu RK, Nyskohus L. Dietary fibre and colorectal cancer: A model for environment–gene interactions. Mol Nutr Food Res 2005;49:571–584.
43.
Beermann C, Jelinek J, Reinecker T, Hauenschild A, Boehm G, Klor HU. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis 2003;2:10.
44.
Bocca C, Bozzo F, Gabriel L, Miglietta A. Conjugated linoleic acid inhibits Caco-2 cell growth via ERKMAPK signaling pathway. J Nutr Biochem 2007;18:332–340.
45.
Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 2005;24:6877–6889.
46.
Xi L, Chen G, Zhou J, Xu G, Wang S, Wu P, Zhu T, Zhang A, Yang W, Xu Q, Lu Y, Ma D. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis 2006;11:789–798.
47.
Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, et al. Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. Cancer Lett 2005;225:199–206.
48.
Magnuson BA, Carr I, Bird RP. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 1993;53:4499–4504.
49.
Sharan S, Kansal VK. Effect of feeding probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on enzymes that catalyse carcinogen activation and detoxification in rats. Milchwissenschaft 2011;66:244–247.
50.
Kaushal D, Kansal VK. Age-related decline in macrophage and lymphocyte functions in mice and its alleviation by treatment with probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum. J Dairy Res 2011a;78:404–411.
51.
Kaushal D, Kansal VK. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum and improves expression of biomarkers of ageing in mice. Mol Biol Rep 2012;39:1791–1799.
52.
Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285–294.
53.
Zang XQ. 1996. Progress of study on suppressor, EFGR and PCNA in colorectal cancer. Xin Xiaohuabingxue Zazhi 1996;4:327–328.

Information & Authors

Information

Published In

cover image Rejuvenation Research
Rejuvenation Research
Volume 17Issue Number 4August 2014
Pages: 325 - 333
PubMed: 24524423

History

Published online: 22 August 2014
Published in print: August 2014
Published ahead of production: 13 February 2014
Accepted: 13 February 2014
Received: 23 November 2013

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Dheeraj Mohania
Animal Biochemistry Division, National Dairy Research Institute (NDRI), Karnal, Haryana, India.
Present address: Department of Research, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi-110060, India.
Vinod K. Kansal
Animal Biochemistry Division, National Dairy Research Institute (NDRI), Karnal, Haryana, India.
Peter Kruzliak
Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic.
Archana Kumari
Food Research and Development Centre, Agriculture and Agri-Food Canada, Saint-Hyacinthe, Quebec, Canada.

Notes

Address correspondence to:Dheeraj MohaniaDepartment of ResearchSir Ganga Ram HospitalRajinder NagarNew Delhi-110060India
E-mail: [email protected]

Author Disclosure Statement

No conflicting financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top